Evaluation of the Hepatocyte-derived Cell Line BFH12 As an in Vitro Model for Bovine Biotransformation

Overview

Journal Cytotechnology

Specialties Biotechnology
Genetics

Date 2019 Jan 9

PMID 30617848

Citations 7

Authors

Alexander Gleich

Bastian Kaiser

Walther Honscha

Herbert Fuhrmann

Axel Schoeniger

Affiliations

Soon will be listed here.

Abstract

The knowledge of drug metabolising enzymes (DMEs) in cattle is rather limited. The capability of the bovine foetal hepatocyte-derived cell line BFH12 to serve as model for biotransformation was evaluated. Gene expression analysis of DMEs was performed by reverse transcription PCR (RT-PCR). The presence of efflux transporters was visualised by immunocytochemistry, and functional induction of cytochrome P450 (CYP) 1A was assessed by the ethoxyresorufin-O-deethylase (EROD) assay. The production of bile acids was measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). RT-PCR revealed the expression of cytochromes 1A1, 1A2, 3A4 and phase II enzymes UGT1A1, UGT1A6 and GSTM1. Immunofluorescence demonstrated efflux transporters ABCG2 and ABCC1. The EROD assay revealed a dose-dependent CYP1A induction after treatment with benzo[a]pyrene (BP). LC-MS/MS analysis of cell culture supernatants showed the production of bile acids including taurocholic acid, tauro-chenodeoxycholic acid, taurodeoxycholic acid and taurolithocholic acid. The results strongly suggest the applicability of the cell line BFH12 for subsequent experiments in the emerging field of bovine biotransformation.

Citing Articles

Establishment and characterization of cytochrome P450 1A1 CRISPR/Cas9 Knockout Bovine Foetal Hepatocyte Cell Line (BFH12).

Iori S, DOnofrio C, Laham-Karam N, Mushimiyimana I, Lucatello L, Lopparelli R Cell Biol Toxicol. 2024; 40(1):18.

PMID: 38528259 PMC: 10963470. DOI: 10.1007/s10565-024-09856-7.

The Bovine Hepatic Cell Line BFH12 as a Possible Model for Hepatosteatosis in Dairy Cows.

Reichelt K, Niebisch A, Kacza J, Schoeniger A, Fuhrmann H Front Vet Sci. 2022; 9:840202.

PMID: 35359674 PMC: 8963807. DOI: 10.3389/fvets.2022.840202.

Synthesis, crystal structure, computational study and anti-virus effect of mixed ligand copper (II) complex with ONS donor Schiff base and 1, 10-phenanthroline.

Mohan B, Choudhary M J Mol Struct. 2021; 1246:131246.

PMID: 34658419 PMC: 8510892. DOI: 10.1016/j.molstruc.2021.131246.

When Two plus Two Is More than Four: Evidence for a Synergistic Effect of Fatty Acids on Peroxisome Proliferator-Activated Receptor Activity in a Bovine Hepatic Model.

Busato S, Bionaz M Genes (Basel). 2021; 12(8).

PMID: 34440457 PMC: 8393910. DOI: 10.3390/genes12081283.

Titanium (IV) complexes of some tetra-dentate symmetrical bis-Schiff bases of 1,6-hexanediamine: Synthesis, characterization, and in silico prediction of potential inhibitor against coronavirus (SARS-CoV-2).

Uddin M, Amin M, Rahman M, Khandaker S, Shumi W, Rahman M Appl Organomet Chem. 2020; 35(1):e6067.

PMID: 33173252 PMC: 7645963. DOI: 10.1002/aoc.6067.

References

Donato M, Castell J, Gomez-Lechon M . Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J Hepatol. 1999; 31(3):542-9. DOI: 10.1016/s0168-8278(99)80049-x. View

Lecluyse E, Madan A, Hamilton G, Carroll K, DeHaan R, Parkinson A . Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J Biochem Mol Toxicol. 2000; 14(4):177-88. DOI: 10.1002/(sici)1099-0461(2000)14:4<177::aid-jbt1>3.0.co;2-4. View

Sivapathasundaram S, Magnisali P, Coldham N, Howells L, Sauer M, Ioannides C . A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver. Biochem Pharmacol. 2001; 62(5):635-45. DOI: 10.1016/s0006-2952(01)00710-9. View

Klocke R, Gomez-Lechon M, Ehrhardt A, Mendoza-Figueroa T, Donato M, Lopez-Revilla R . Establishment and characterization of immortal hepatocytes derived from various transgenic mouse lines. Biochem Biophys Res Commun. 2002; 294(4):864-71. DOI: 10.1016/S0006-291X(02)00579-X. View

Rodriguez-Antona C, Donato M, Boobis A, Edwards R, WATTS P, Vicente Castell J . Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica. 2002; 32(6):505-20. DOI: 10.1080/00498250210128675. View

Trauner M, Boyer J . Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003; 83(2):633-71. DOI: 10.1152/physrev.00027.2002. View

Cui Y, Konig J, Nies A, Pfannschmidt M, Hergt M, Franke W . Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab Invest. 2003; 83(4):527-38. DOI: 10.1097/01.lab.0000065015.02412.48. View

Brandon E, Raap C, Meijerman I, Beijnen J, Schellens J . An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol. 2003; 189(3):233-46. DOI: 10.1016/s0041-008x(03)00128-5. View

Machala M, Soucek P, Neca J, Ulrich R, Lamka J, Szotakova B . Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants. Arch Toxicol. 2003; 77(10):555-60. DOI: 10.1007/s00204-003-0477-4. View

10.

Jonker J, Schinkel A . Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther. 2003; 308(1):2-9. DOI: 10.1124/jpet.103.053298. View

11.

Lazaro C, Croager E, Mitchell C, Campbell J, Yu C, Foraker J . Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology. 2003; 38(5):1095-106. DOI: 10.1053/jhep.2003.50448. View

12.

Plant N . Strategies for using in vitro screens in drug metabolism. Drug Discov Today. 2004; 9(7):328-36. DOI: 10.1016/s1359-6446(03)03019-8. View

13.

Sivapathasundaram S, Howells L, Sauer M, Ioannides C . Functional integrity of precision-cut liver slices from deer and cattle. J Vet Pharmacol Ther. 2004; 27(2):79-84. DOI: 10.1111/j.1365-2885.2004.00555.x. View

14.

Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, Zahn A . Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology. 2004; 127(1):26-40. DOI: 10.1053/j.gastro.2004.04.019. View

15.

Grasso E, Longo V, Coceani F, Gervasi P . Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle. Biochim Biophys Acta. 2005; 1722(2):116-23. DOI: 10.1016/j.bbagen.2004.11.018. View

16.

Dacasto M, Eeckhoutte C, Capolongoa F, Dupuy J, Carletti M, Calleja C . Effect of breed and gender on bovine liver cytochrome P450 3A (CYP3A) expression and inter-species comparison with other domestic ruminants. Vet Res. 2005; 36(2):179-90. DOI: 10.1051/vetres:2004066. View

17.

Priesner C, Hesse F, Windgassen D, Klocke R, Paul D, Wagner R . Liver-specific physiology of immortal, functionally differentiated hepatocytes and of deficient hepatocyte-like variants. In Vitro Cell Dev Biol Anim. 2005; 40(10):318-30. DOI: 10.1290/0404031.1. View

18.

Halwachs S, Kneuer C, Honscha W . Endogenous expression of liver-specific drug transporters for organic anions in the rat hepatocytoma fusion cell line HPCT-1E3. Eur J Cell Biol. 2005; 84(7):677-86. DOI: 10.1016/j.ejcb.2005.01.008. View

19.

Deeley R, Cole S . Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 2006; 580(4):1103-11. DOI: 10.1016/j.febslet.2005.12.036. View

20.

Gusson F, Carletti M, Albo A, Dacasto M, Nebbia C . Comparison of hydrolytic and conjugative biotransformation pathways in horse, cattle, pig, broiler chick, rabbit and rat liver subcellullar fractions. Vet Res Commun. 2006; 30(3):271-83. DOI: 10.1007/s11259-006-3247-y. View